BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA)

CUSIP: 09077V100

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class
Equity / Common Stock, par value $0.00001 per share
Total 13F shares
23,662,525
Total 13F value
$314,117,431
Holder snapshot 6 visible 7 signals
Share change
+1,599,516
Put/Call ratio
0%
SEC-reported price per share
$13.23
Number of holders
113
Value change
+$36,761,604
Number of buys
64
Open additional details 1 more signal available
Number of sells
32
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
44,967,550

Security key

09077V100

Report period

Q4 2025

Institutions

113

Top holders

10

BIOA full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2026 Previous quarter: Q3 2025 BioAge Labs, Inc. SEC filings BioAge Labs, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BIOA - BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Kristen Fortney
Disclosed value leader
Kristen Fortney
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F 3/4/5 Lead comparable stake: 7.2% 13D/G row: Kristen Fortney Showing 1-6 of 15 holder rows.

Quick read

Kristen Fortney leads the comparable SEC ownership view at 7.2%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Kristen Fortney's linked filing trail.
Comparable ownership Top 5
Kristen Fortney 7.2%
RA CAPITAL MANAGEMENT, L.P. 3.7%
ADAR1 Capital Management, LLC 0.4%
a16z Capital Management, L.L.C. 7.2%
Sofinnova Investments, Inc. 5.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Kristen Fortney
13D/G
13D/G
7.2%
$48,279,538
2,704,736 shares
 $0 31 Dec 2025
RA CAPITAL MANAGEMENT, L.P.
13D/G
13D/G
3.7%
$5,740,380
1,310,589 shares
 $0 31 Dec 2024
ADAR1 Capital Management, LLC
13F 13D/G
Company
13F 13D/G
0.4%
from 13D/G
$11,054,829
1,880,073 shares
 — 30 Sep 2025
a16z Capital Management, L.L.C.
13F
Company
13F
7.2%
$19,011,040
3,233,170 shares
 — 30 Sep 2025
Sofinnova Investments, Inc.
13F
Company
13F
5.1%
$13,487,473
2,293,788 shares
 — 30 Sep 2025
Cormorant Asset Management, LP
3/4/5 13F
Former 10% Owner · Company
3/4/5 13F
4.8%
from 13F
$29,331,522
1,629,529 shares
 — 27 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
113
Shares
23,662,525
Rows available
113
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
92
Q4 2025 holders
113
Holder diff
21
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .